DWY48ZZ
Other Radiation Hemibody to None with None, Hyperthermia Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | W Anatomical Regions |
| Operation | Y Other Radiation |
| Body Part | 4 Hemibody |
| Approach | 8 Hyperthermia |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
This family captures radiation treatments to an anatomical region that don't fit the standard categories of external beam, brachytherapy, or stereotactic radiosurgery, such as systemic radiopharmaceutical therapy, intraoperative techniques not otherwise classified, or other delivery methods documented as distinct from those three approaches. It's used when the treatment targets a region spanning tissue not confined to one classified organ.
Clinically, this may apply to palliative treatment of widespread regional disease, certain radioisotope therapies that circulate to affect a region rather than being locally implanted or externally beamed, or newer or less common delivery techniques the treating physician documents outside the usual modality descriptions. As with other radiation therapy, planning weighs the benefit to the treated area against exposure to nearby organs and expected side effects.
Anatomy & Axis Detail
Hemibody
Hemibody irradiation treats one half of the body, typically the upper or lower half divided at roughly the level of the umbilicus, most often used for widespread painful bone metastases when disease is too extensive for focal treatment to be practical. This body part designation reflects large-field palliative radiation intended to relieve pain across multiple skeletal sites simultaneously rather than to treat a single organ or lesion, and it carries a distinct toxicity profile including risk of significant bone marrow suppression and gastrointestinal side effects because so much tissue is irradiated at once. The choice between upper and lower hemibody, or sequential treatment of both halves, depends on the distribution of the patient's metastatic disease and their overall marrow reserve.
Modality Qualifier: Hyperthermia
Hyperthermia in this context is the therapeutic elevation of tissue temperature, typically used as an adjunct alongside other radiation modalities to sensitize tumor cells and improve treatment response. Unlike the particle or photon beam entries in this list, it does not itself deliver ionizing radiation but is coded as a distinct qualifier because it modifies how a concurrent radiation treatment is delivered and documented.
Coding & Documentation
This code is assigned only when the treatment record clearly states a modality other than beam radiation, brachytherapy, or stereotactic radiosurgery, together with the anatomical region treated and enough detail to identify the qualifier for the technique used. Because this is a residual category, coders should first rule out whether the documentation actually describes one of the three primary modalities before defaulting here. The most frequent mistake is using this code as a catch-all when the note is simply vague, rather than querying the physician to clarify the actual delivery method, which can result in under- or overstating the complexity of the treatment.
Commonly Confused With
The main distinction to check against is any of the other three Anatomical Regions radiation families, Beam Radiation, Brachytherapy, and Stereotactic Radiosurgery, since this code should only be used when none of those specifically describes the documented technique. It's also worth distinguishing from Other Radiation coded to a specific organ system, which applies when the note names a discrete organ rather than a broader region.